Indian rupee, the domestic currency benchmark gained 18 paise to 74.73 per dollar on Tuesday, tracking positive domestic equities and hopes of COVID-19 vaccine.
At the interbank forex market, rupee opened at 74.79 per dollar and later gained further ground to touch 74.73 per dollar, up 18 paise over its previous close of 74.91 on Monday.
Positive domestic as well as global equities, foreign fund inflows and hopes of COVID-19 vaccine supported the domestic unit.
On the contrary, the dollar index, which gauges the greenback's strength against a basket of six currencies, was rising 0.04% to 95.87.
A coronavirus vaccine created by the University of Oxford appears safe and induces a strong immune response within the body, scientists announced on Monday after the first phase of human trials.
In India, AIIMS-Delhi on Monday began recruiting volunteers for conducting human clinical trials of the indigenously developed COVID-19 vaccine candidate Covaxin.
On the domestic equity market front, the 30-share BSE benchmark Sensex was trading 387.14 points higher at 37,806.13 and broader NSE Nifty rose 110.25 points to 11,132.45.
Foreign institutional investors were net buyers in the capital market as they purchased shares worth Rs 1,709.97 crore on Monday, according to provisional exchange data.
Brent crude futures, the global oil benchmark, rose 0.14 per cent to USD 43.34 per barrel.
Meanwhile, the number of cases around the world linked to COVID-19 has crossed 1.47 crore and the death toll has topped 6.09 lakh.
In India, the death toll due the disease rose to 28,084 and the number of infections has touched 11,55,191, according to the health ministry.
(With PTI Inputs)
Copyright©2022 Living Media India Limited. For reprint rights: Syndications Today